These individuals develop and support in vitro, molecular, and cell-based techniques and assays for cellular and gene therapies. They use qPCR and/or ddPCR technologies to assess biodistribution, vector shedding, gene expression, formulation, and stability of novel therapeutics in preclinical and clinical studies. They also follow GxP’s, SOPs, and study protocols to accurately document methods, procedures, and results for study reports and regulatory documents.